HEC169096
/ Sunshine Lake Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
April 29, 2026
HEC169096 in Participants With Advanced Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=456 | Recruiting | Sponsor: Sunshine Lake Pharma Co., Ltd. | Trial primary completion date: Jul 2025 ➔ Dec 2026
Trial primary completion date • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • Thyroid Gland Carcinoma
October 27, 2022
HEC169096 in Participants With Advanced Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=456 | Recruiting | Sponsor: Sunshine Lake Pharma Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Endocrine Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • Thyroid Gland Carcinoma
July 11, 2022
HEC169096 in Participants With Advanced Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=376 | Not yet recruiting | Sponsor: Sunshine Lake Pharma Co., Ltd.
New P1/2 trial • Endocrine Cancer • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor • Thyroid Gland Carcinoma
1 to 3
Of
3
Go to page
1